UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Signatures of copy number alterations in human cancer

Steele, Christopher D; Abbasi, Ammal; Islam, SM Ashiqul; Bowes, Amy L; Khandekar, Azhar; Haase, Kerstin; Hames-Fathi, Shadi; ... Pillay, Nischalan; + view all (2022) Signatures of copy number alterations in human cancer. Nature 10.1038/s41586-022-04738-6. (In press). Green open access

[thumbnail of Flanagan_Signatures of copy number alterations in human cancer_AOP.pdf]
Preview
Text
Flanagan_Signatures of copy number alterations in human cancer_AOP.pdf - Published Version

Download (15MB) | Preview

Abstract

Gains and losses of DNA are prevalent in cancer and emerge as a consequence of inter-related processes of replication stress, mitotic errors, spindle multipolarity and breakage–fusion–bridge cycles, among others, which may lead to chromosomal instability and aneuploidy1,2. These copy number alterations contribute to cancer initiation, progression and therapeutic resistance3,4,5. Here we present a conceptual framework to examine the patterns of copy number alterations in human cancer that is widely applicable to diverse data types, including whole-genome sequencing, whole-exome sequencing, reduced representation bisulfite sequencing, single-cell DNA sequencing and SNP6 microarray data. Deploying this framework to 9,873 cancers representing 33 human cancer types from The Cancer Genome Atlas6 revealed a set of 21 copy number signatures that explain the copy number patterns of 97% of samples. Seventeen copy number signatures were attributed to biological phenomena of whole-genome doubling, aneuploidy, loss of heterozygosity, homologous recombination deficiency, chromothripsis and haploidization. The aetiologies of four copy number signatures remain unexplained. Some cancer types harbour amplicon signatures associated with extrachromosomal DNA, disease-specific survival and proto-oncogene gains such as MDM2. In contrast to base-scale mutational signatures, no copy number signature was associated with many known exogenous cancer risk factors. Our results synthesize the global landscape of copy number alterations in human cancer by revealing a diversity of mutational processes that give rise to these alterations.

Type: Article
Title: Signatures of copy number alterations in human cancer
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41586-022-04738-6
Publisher version: https://doi.org/10.1038/s41586-022-04738-6
Language: English
Additional information: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Cancer genomics; Genome informatics
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Pathology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10150964
Downloads since deposit
8,740Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item